Home Cabrellis Pharmaceuticals

Cabrellis Pharmaceuticals

acquired
Series A
Cancer Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Cabrellis Pharmaceuticals is a company dedicated to the research and development of cancer treatment drugs. Cabrellis plans to launch three independent clinical trials in small cell lung cancer (SCLC) in 2006.
Cabrellis Pharmaceuticals Corporation
SanDiego,California,United States of America
unclear
January 01, 2006
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Lung Cancer
Application Scenarios
Innovative Drugs